Volume 10, Issue 3 , Pages 147-149, September 2010
Although Randomized Controlled Trials Support the Evidence Base for the Several Different Measures to Prevent or Manage Xerostomia Following Cancer Treatment, Intensity-Modified Radiotherapy (IMRT) Should be Used When Possible
Article Title and Bibliographic Information
A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact.
Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN, Dutilh J, et al.
Support Care Cancer. 2010 Mar 25. [Epub ahead of print.]
Reviewer
Simon N. Rogers, FDS, RCS, FRCS, MD
Purpose/Question
What is the evidence in support of different management strategies for salivary gland hypofunction and xerostomia caused by cancer treatments?
Source of Funding
Information not available
Type of Study/Design
Systematic review
Level of Evidence
Level 1: Good-quality, patient-oriented evidence
Strength of Recommendation Grade
Grade A: Consistent, good-quality patient-oriented evidence
To access this article, please choose from the options below
PII: S1532-3382(10)00136-3
doi:10.1016/j.jebdp.2010.06.005
© 2010 Elsevier Inc. All rights reserved.
Volume 10, Issue 3 , Pages 147-149, September 2010
